A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin

This study is comparing a new investigational diabetes drug called HRS-7535 against an existing medication (dapagliflozin) for people with Type 2 diabetes whose blood sugar is not well controlled on metformin alone. The goal is to see if the new drug controls blood sugar as well or better. **You may be eligible if...** - You are between 18 and 75 years old - You have had Type 2 diabetes for at least 3 months - Your HbA1c (a measure of blood sugar control over 3 months) is between 7.5% and 11% - You have been on a stable dose of metformin (at least 1,500 mg/day) for at least 8 weeks **You may NOT be eligible if...** - You have Type 1 diabetes or another form of diabetes - You have had a serious diabetes emergency (e.g., ketoacidosis) in the past 6 months - You have active eye complications, painful nerve damage, a diabetic foot ulcer, or severe circulation problems requiring treatment - You are pregnant, breastfeeding, or planning to become pregnant during the study Talk to your doctor to see if this trial is right for you.